Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically Pushkar AggarwalNathan L. BowersSteven R. Feldman Commentary Open access 04 February 2022 Pages: 611 - 614
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma Akimichi MoritaChiharu TateishiDaisuke Tsuruta Original Research Open access 27 January 2022 Pages: 615 - 629
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents Robert SidburySady AlpizarChristophe Piketty Original Research Open access 28 January 2022 Pages: 631 - 642
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides Carolina V. Alexander-SavinoCatherine G. ChungBrian Poligone Original Research Open access 05 February 2022 Pages: 643 - 654
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis Xinyu WangMing ZhangYanqing Gao Original Research Open access 29 January 2022 Pages: 655 - 670
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic Maria EspositoAnna CampanatiMaria Concetta Fargnoli Original Research Open access 01 February 2022 Pages: 671 - 681
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study Véronique VendrelyAnder Mayor-IbargurenAriadna Ortiz-Brugués Original Research Open access 02 February 2022 Pages: 683 - 699
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab Andrew BlauveltRussel BurgeBenjamin Lockshin Original Research Open access 26 February 2022 Pages: 701 - 714
Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial Endi NoviantoTjut N. A. JacoebRetno W. Soebaryo Original Research Open access 17 February 2022 Pages: 715 - 726
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis Andrew BlauveltMelinda GooderhamMark Lebwohl Original Research Open access 23 February 2022 Pages: 727 - 740
Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database Timothy FitzgeraldAimee M. NearKatelyn Rowland Original Research Open access 24 February 2022 Pages: 741 - 752
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis George GondoEdward HadelerWilson Liao Original Research Open access 07 March 2022 Pages: 753 - 760
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago Laida ElberdínRosa M. Fernández-TorresEduardo Fonseca Original Research Open access 28 February 2022 Pages: 761 - 770
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study Andrew AlexisMarjolein de Bruin-WellerNatalie Yin Original Research Open access 17 March 2022 Pages: 771 - 785
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17 April W. ArmstrongAndrew BlauveltRichard B. Warren Practical Approach Open access 15 February 2022 Pages: 787 - 800
A Case of New-Onset Lichen Planus after COVID-19 Vaccination Vincenzo PiconeGabriella FabbrociniFabrizio Martora Case Report Open access 15 February 2022 Pages: 801 - 805